Doc re. Supp. Listing Parts.
March 12 2002 - 10:11AM
UK Regulatory
RNS Number:8446S
Cambridge Antibody Tech Group PLC
12 March 2002
Doc Re Supplementary Listing Particulars relating to the issue of up to
4,183,672 new ordinary shares of 10 pence each in CAT in connection with the
offer by 3982904 Canada Inc. (a wholly owned subsidiary of Cambridge Antibody
Technology Group plc) for Drug Royalty Corporation Inc.
A Copy of the above document has been submitted to the UK Listing Authority,
and will shortly be available for inspection at the UK Listing Authority's
Document Viewing Facility, which is situated at:
Financial Services Authority
25 The North Colonnade
Canary Wharf
London
E14 5HS
Tel. no. (0)20 7676 1000
(Documents will usually be available for inspection within six normal business
hours of this notice being given).
This information is provided by RNS
The company news service from the London Stock Exchange
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Aug 2023 to Aug 2024